$ATRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adhera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adhera Therapeutics, Inc.. Get notifications about new insider transactions in Adhera Therapeutics, Inc. for free.
Page: < prev 1 ... 4 5 6 7 8 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 03 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.45 | 117 | 1,223 | 366,987 | 367.1 K to 367 K (-0.03 %) |
| May 03 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.42 | 300 | 3,126 | 367,104 | 367.4 K to 367.1 K (-0.08 %) |
| May 03 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.40 | 200 | 2,080 | 367,404 | 367.6 K to 367.4 K (-0.05 %) |
| May 03 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.38 | 100 | 1,038 | 367,604 | 367.7 K to 367.6 K (-0.03 %) |
| May 03 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.31 | 283 | 2,918 | 367,704 | 368 K to 367.7 K (-0.08 %) |
| Apr 18 2005 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 10.33 | 1,100 | 11,363 | 24,500 | 23.4 K to 24.5 K (+4.70 %) |
| Apr 18 2005 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 10.32 | 100 | 1,032 | 23,400 | 23.3 K to 23.4 K (+0.43 %) |
| Apr 18 2005 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 10.30 | 700 | 7,210 | 23,300 | 22.6 K to 23.3 K (+3.10 %) |
| Apr 18 2005 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 10.29 | 100 | 1,029 | 22,600 | 22.5 K to 22.6 K (+0.44 %) |
| Apr 18 2005 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 10.28 | 800 | 8,224 | 22,500 | 21.7 K to 22.5 K (+3.69 %) |
| Apr 18 2005 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 10.26 | 100 | 1,026 | 21,700 | 21.6 K to 21.7 K (+0.46 %) |
| Apr 18 2005 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 10.25 | 100 | 1,025 | 21,600 | 21.5 K to 21.6 K (+0.47 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Option Exercise | X | 4.75 | 10,000 | 47,500 | 68,000 | |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Option Exercise | X | 5.13 | 10,000 | 51,250 | 78,000 | |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Sell | S | 10.53 | 1,980 | 20,844 | 16,333 | 18.3 K to 16.3 K (-10.81 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Sell | S | 10.60 | 400 | 4,240 | 18,313 | 18.7 K to 18.3 K (-2.14 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Sell | S | 10.61 | 2,620 | 27,797 | 18,713 | 21.3 K to 18.7 K (-12.28 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Sell | S | 10.71 | 5,000 | 53,534 | 21,333 | 26.3 K to 21.3 K (-18.99 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Sell | S | 10.65 | 5,000 | 53,248 | 26,333 | 31.3 K to 26.3 K (-15.96 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Sell | S | 10.63 | 5,000 | 53,128 | 31,333 | 36.3 K to 31.3 K (-13.76 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Buy | M | 4.75 | 10,000 | 47,500 | 36,333 | 26.3 K to 36.3 K (+37.98 %) |
| Apr 13 2005 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Buy | M | 5.13 | 10,000 | 51,250 | 26,333 | 16.3 K to 26.3 K (+61.23 %) |
| Apr 06 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.12 | 600 | 6,071 | 367,987 | 368.6 K to 368 K (-0.16 %) |
| Apr 06 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.05 | 200 | 2,010 | 368,587 | 368.8 K to 368.6 K (-0.05 %) |
| Apr 06 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.00 | 200 | 2,000 | 368,787 | 369 K to 368.8 K (-0.05 %) |
| Apr 06 2005 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 9.95 | 1,300 | 12,935 | 97,212 | 95.9 K to 97.2 K (+1.36 %) |
| Mar 21 2005 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 9.50 | 1,700 | 16,150 | 95,912 | 94.2 K to 95.9 K (+1.80 %) |
| Mar 21 2005 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 9.50 | 300 | 2,850 | 94,212 | 93.9 K to 94.2 K (+0.32 %) |
| Mar 11 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.00 | 400 | 4,000 | 368,987 | 369.4 K to 369 K (-0.11 %) |
| Mar 03 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.08 | 200 | 2,016 | 369,387 | 369.6 K to 369.4 K (-0.05 %) |
| Mar 03 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.03 | 400 | 4,010 | 369,587 | 370 K to 369.6 K (-0.11 %) |
| Feb 02 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.59 | 1,000 | 10,590 | 369,987 | 371 K to 370 K (-0.27 %) |
| Jan 25 2005 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Senior Vice Preside ... | Option Exercise | A | 10.39 | 4,000 | 41,560 | 94,000 | |
| Jan 25 2005 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Senior Vice Preside ... | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
| Jan 25 2005 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Option Exercise | A | 10.39 | 7,500 | 77,925 | 122,500 | |
| Jan 25 2005 | MRNA | Marina Biotech, In ... | BRANDT GORDON | Exec VP of Science ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Jan 04 2005 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.07 | 1,000 | 12,070 | 370,987 | 372 K to 371 K (-0.27 %) |
| Dec 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 15.20 | 1,000 | 15,202 | 371,987 | 373 K to 372 K (-0.27 %) |
| Dec 02 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | X | 5.13 | 2,000 | 10,250 | 128,500 | |
| Dec 02 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Sell | S | 15.34 | 2,000 | 30,683 | 101,041 | 103 K to 101 K (-1.94 %) |
| Dec 02 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | M | 5.13 | 2,000 | 10,250 | 103,041 | 101 K to 103 K (+1.98 %) |
| Nov 24 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 16.00 | 2,000 | 32,000 | 372,987 | 375 K to 373 K (-0.53 %) |
| Nov 23 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | X | 5.13 | 500 | 2,563 | 130,500 | |
| Nov 23 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | X | 5.13 | 500 | 2,563 | 131,000 | |
| Nov 23 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Sell | S | 16.22 | 500 | 8,110 | 101,041 | 101.5 K to 101 K (-0.49 %) |
| Nov 23 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | M | 5.13 | 500 | 2,563 | 101,541 | 101 K to 101.5 K (+0.49 %) |
| Nov 23 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Sell | S | 15.00 | 500 | 7,500 | 101,041 | 101.5 K to 101 K (-0.49 %) |
| Nov 23 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | M | 5.13 | 500 | 2,563 | 101,541 | 101 K to 101.5 K (+0.49 %) |
| Nov 17 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | X | 5.13 | 1,500 | 7,688 | 131,500 | |
| Nov 17 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Sell | S | 14.18 | 1,500 | 21,276 | 101,041 | 102.5 K to 101 K (-1.46 %) |
| Nov 17 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | M | 5.13 | 1,500 | 7,688 | 102,541 | 101 K to 102.5 K (+1.48 %) |
| Nov 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.15 | 300 | 4,245 | 374,987 | 375.3 K to 375 K (-0.08 %) |
| Nov 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.05 | 200 | 2,810 | 375,287 | 375.5 K to 375.3 K (-0.05 %) |
| Nov 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.25 | 500 | 6,625 | 375,487 | 376 K to 375.5 K (-0.13 %) |
| Oct 28 2004 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 13.60 | 2,000 | 27,200 | 93,912 | 91.9 K to 93.9 K (+2.18 %) |
| Oct 15 2004 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | President, CEO and ... | Option Exercise | X | 4.09 | 30,000 | 122,700 | 1,306,719 | |
| Oct 15 2004 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | President, CEO and ... | Buy | M | 4.09 | 30,000 | 122,700 | 193,281 | 163.3 K to 193.3 K (+18.37 %) |
| Oct 15 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | X | 4.75 | 10,000 | 47,500 | 133,000 | |
| Oct 15 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | M | 4.75 | 10,000 | 47,500 | 101,041 | 91 K to 101 K (+10.98 %) |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | President, CEO and ... | Option Exercise | X | 4.09 | 60,000 | 245,400 | 1,336,719 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | President, CEO and ... | Buy | M | 4.09 | 60,000 | 245,400 | 163,281 | 103.3 K to 163.3 K (+58.09 %) |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.15 | 2,150 | 28,273 | 127,500 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.25 | 1,550 | 20,538 | 129,650 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.20 | 1,100 | 14,520 | 131,200 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.18 | 1,000 | 13,180 | 132,300 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.35 | 400 | 5,340 | 133,300 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.27 | 300 | 3,981 | 133,700 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.26 | 300 | 3,978 | 134,000 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.21 | 200 | 2,642 | 134,300 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.17 | 100 | 1,317 | 134,500 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.23 | 100 | 1,323 | 134,600 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.28 | 100 | 1,328 | 134,700 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.29 | 100 | 1,329 | 134,800 | |
| Oct 12 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | S | 13.34 | 100 | 1,334 | 134,900 | |
| Oct 08 2004 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Buy | P | 13.68 | 5,000 | 68,422 | 21,500 | 16.5 K to 21.5 K (+30.30 %) |
| Oct 06 2004 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 14.00 | 1,100 | 15,400 | 149,412 | 148.3 K to 149.4 K (+0.74 %) |
| Oct 06 2004 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 13.99 | 100 | 1,399 | 148,312 | 148.2 K to 148.3 K (+0.07 %) |
| Oct 06 2004 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 13.98 | 1,800 | 25,164 | 148,212 | 146.4 K to 148.2 K (+1.23 %) |
| Oct 06 2004 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 13.97 | 800 | 11,176 | 146,412 | 145.6 K to 146.4 K (+0.55 %) |
| Oct 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.25 | 300 | 4,275 | 376,153 | 376.5 K to 376.2 K (-0.08 %) |
| Oct 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.00 | 300 | 4,200 | 376,453 | 376.8 K to 376.5 K (-0.08 %) |
| Oct 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.95 | 200 | 2,790 | 376,753 | 377 K to 376.8 K (-0.05 %) |
| Oct 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.80 | 100 | 1,380 | 376,953 | 377.1 K to 377 K (-0.03 %) |
| Oct 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.75 | 100 | 1,375 | 377,053 | 377.2 K to 377.1 K (-0.03 %) |
| Aug 12 2004 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Option Exercise | A | 8.83 | 1,500 | 13,245 | 16,500 | |
| Aug 12 2004 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Grant | A | 0.00 | 1,500 | 0 | 16,500 | 15 K to 16.5 K (+10.00 %) |
| Sep 27 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.70 | 500 | 5,350 | 377,153 | 377.7 K to 377.2 K (-0.13 %) |
| Sep 27 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.62 | 100 | 1,062 | 377,653 | 377.8 K to 377.7 K (-0.03 %) |
| Sep 27 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.58 | 400 | 4,232 | 377,753 | 378.2 K to 377.8 K (-0.11 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.28 | 100 | 1,028 | 378,153 | 378.3 K to 378.2 K (-0.03 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.25 | 200 | 2,050 | 378,253 | 378.5 K to 378.3 K (-0.05 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.22 | 100 | 1,022 | 378,453 | 378.6 K to 378.5 K (-0.03 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.14 | 100 | 1,014 | 378,553 | 378.7 K to 378.6 K (-0.03 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.11 | 100 | 1,011 | 378,653 | 378.8 K to 378.7 K (-0.03 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.10 | 200 | 2,020 | 378,753 | 379 K to 378.8 K (-0.05 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.05 | 100 | 1,005 | 378,953 | 379.1 K to 379 K (-0.03 %) |
| Jul 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.04 | 100 | 1,004 | 379,053 | 379.2 K to 379.1 K (-0.03 %) |
| Jun 29 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | M | 5.63 | 95,000 | 534,375 | 48,000 | |
| Jun 29 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Buy | M | 5.63 | 95,000 | 534,375 | 379,153 | 284.2 K to 379.2 K (+33.43 %) |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Option Exercise | A | 11.24 | 15,000 | 168,600 | 15,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | Duffy Timothy M | VP of Business Devp | Option Exercise | A | 11.24 | 15,000 | 168,600 | 15,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | Duffy Timothy M | VP of Business Devp | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | HOLUBIAK MYRON Z | Director | Option Exercise | A | 11.24 | 15,000 | 168,600 | 15,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | HOLUBIAK MYRON Z | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Option Exercise | A | 11.24 | 15,000 | 168,600 | 15,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | MICHELSON LESLIE D | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | A | 11.24 | 3,000 | 33,720 | 143,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Grant | A | 0.00 | 3,000 | 0 | 284,153 | 281.2 K to 284.2 K (+1.07 %) |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | A | 11.24 | 3,000 | 33,720 | 143,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Grant | A | 0.00 | 3,000 | 0 | 91,041 | 88 K to 91 K (+3.41 %) |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Option Exercise | A | 11.24 | 3,000 | 33,720 | 98,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Grant | A | 0.00 | 3,000 | 0 | 6,333 | 3.3 K to 6.3 K (+90.01 %) |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | FERRIER IAN R | Director | Option Exercise | A | 11.24 | 3,000 | 33,720 | 13,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | FERRIER IAN R | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Option Exercise | A | 11.24 | 3,000 | 33,720 | 58,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | BEESE J CARTER JR | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Option Exercise | A | 11.24 | 7,500 | 84,300 | 90,834 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | WEAVER GREGORY L | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 8,500 | 1,000 to 8.5 K (+750.00 %) |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Option Exercise | S | 4.13 | 10,000 | 41,250 | 88,000 | |
| Jun 14 2004 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Buy | S | 4.13 | 10,000 | 41,250 | 16,333 | 6.3 K to 16.3 K (+157.90 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.76 | 100 | 1,176 | 281,153 | 281.3 K to 281.2 K (-0.04 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.74 | 100 | 1,174 | 281,253 | 281.4 K to 281.3 K (-0.04 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.55 | 200 | 2,310 | 281,353 | 281.6 K to 281.4 K (-0.07 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.50 | 200 | 2,300 | 281,553 | 281.8 K to 281.6 K (-0.07 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.45 | 100 | 1,145 | 281,753 | 281.9 K to 281.8 K (-0.04 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.41 | 100 | 1,141 | 281,853 | 282 K to 281.9 K (-0.04 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.40 | 100 | 1,140 | 281,953 | 282.1 K to 282 K (-0.04 %) |
| Jun 01 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.39 | 100 | 1,139 | 282,053 | 282.2 K to 282.1 K (-0.04 %) |
| May 11 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | X | 4.13 | 10,000 | 41,250 | 140,000 | |
| May 11 2004 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | X | 4.13 | 10,000 | 41,250 | 88,041 | 78 K to 88 K (+12.81 %) |
| May 03 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.79 | 100 | 1,379 | 282,153 | 282.3 K to 282.2 K (-0.04 %) |
| May 03 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.78 | 300 | 4,134 | 282,253 | 282.6 K to 282.3 K (-0.11 %) |
| May 03 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.77 | 400 | 5,508 | 282,553 | 283 K to 282.6 K (-0.14 %) |
| May 03 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.76 | 200 | 2,752 | 282,953 | 283.2 K to 283 K (-0.07 %) |
| Apr 15 2004 | MRNA | Marina Biotech, In ... | WORMUTH DAVID E | Senior Vice Preside ... | Option Exercise | A | 13.90 | 25,000 | 347,500 | 135,000 | |
| Apr 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.20 | 400 | 5,280 | 283,153 | 283.6 K to 283.2 K (-0.14 %) |
| Apr 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.11 | 200 | 2,622 | 283,553 | 283.8 K to 283.6 K (-0.07 %) |
| Apr 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.09 | 200 | 2,618 | 283,753 | 284 K to 283.8 K (-0.07 %) |
| Apr 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.00 | 200 | 2,600 | 283,953 | 284.2 K to 284 K (-0.07 %) |
| Mar 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.26 | 100 | 1,126 | 284,153 | 284.3 K to 284.2 K (-0.04 %) |
| Mar 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.25 | 500 | 5,625 | 284,253 | 284.8 K to 284.3 K (-0.18 %) |
| Mar 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.02 | 100 | 1,102 | 284,753 | 284.9 K to 284.8 K (-0.04 %) |
| Mar 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.01 | 200 | 2,201 | 284,853 | 285.1 K to 284.9 K (-0.07 %) |
| Mar 02 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 11.00 | 100 | 1,100 | 285,053 | 285.2 K to 285.1 K (-0.04 %) |
| Feb 25 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | X | 4.13 | 10,000 | 41,250 | 140,000 | |
| Feb 25 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Option Exercise | X | 3.38 | 50,000 | 168,750 | 150,000 | |
| Feb 25 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Buy | X | 4.13 | 10,000 | 41,250 | 285,153 | 275.2 K to 285.2 K (+3.63 %) |
| Feb 25 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Buy | X | 3.38 | 50,000 | 168,750 | 275,153 | 225.2 K to 275.2 K (+22.21 %) |
| Feb 18 2004 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 10.10 | 797 | 8,050 | 225,153 | 226 K to 225.2 K (-0.35 %) |